immunization procedures

Phase 3Biologic

CChangchun Zhuoyi Biological Co., Ltd

immunization procedures is one of 40 biologic programs targeting Prevention. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

PreventionEnrolling by invitation

PreventionPhase 3

Enrolling by invitation

Competition

Competitive Landscape

46 competitors in Prevention

#DrugCompanyPhaseTrials

Glucophage

EMD Serono

Approved

8 2

Prograf

VVeloxis Pharmaceuticals

Phase 3

4 3

Prolia

OOrganon and Co

Phase 3

2 4

Fludara

Sanofi

Phase 2

2 5

Nolvadex

AstraZeneca

Phase 2

2 6

Orencia

Bristol-Myers Squibb

Phase 2

2 7

Yescarta

Gilead

Phase 2

1 8

Ilaris

Novartis

Phase 2

1 9

Cytoxan

BBaxter Healthcare Corporation

Phase 2

7 10

BCG Vaccine

GGynecologic Oncology Group

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Prevention1 trial

Prevention of Rabies With Four Doses of Rabies Vaccine

Enrolling by invitation·CChangchun Zhuoyi Biological Co., Ltd·Phase 3·NCT05545371·2,100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for immunization procedures. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — immunization procedures compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for immunization procedures. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Changchun Zhuoyi Biological Co., Ltd company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Phase 3[1]
Company: CChangchun Zhuoyi Biological Co., Ltd

immunization procedures

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Prevention1 trial

References

Drug Info

Quick Facts

Related News